The CTX-DP immortalized cell line comes from human first-trimester fetal cortical cells and was genetically modified using c-mycER TAM technology to attain conditional growth control using a fusion protein comprising a growth-promoting gene, c-myc, and a hormone receptor regulated with the synthetic medication, 4-hydroxytamoxifen.3 SB623 cells exhibit a neuronal phenotype when extended from human bone… Continue reading The CTX-DP immortalized cell line comes from human first-trimester fetal cortical